With our in-house technology platform, scientific expertise in the inner ear, and network of experts, Sensorion can continually develop and optimize its pipeline and market expertise. Consequently, we are poised to expand our pipeline and facilitate other pharmaceutical collaborations.

We select and develop drug candidates from a pool of compounds in late pre-clinical and clinical stage development obtained from partnerships, collaborations and publically available drug libraries.

20200910 Pipeline

 

Latest news

  • 18 Sep 2020

    Sensorion successfully raises approximately €31 (US$ 36.5) million in an oversubscribed private placement to US and European investors. Read

  • 17 Sep 2020

    Sensorion launches a capital increase by means of an accelerated bookbuild offering. Read

Patient center

Corporate presentation